Kuehne dismisses DSV threat – all set for 'sustainable profitable market share growth'
It’s easy to say…
Pharma is “a growth market” for ocean carriers as shippers become cost- and emissions-conscious, but temperature and time-sensitive requirements could mean a liner’s “piece of the pie” will only be a sliver.
Cathy O’Brien, VP of international sales at UPS Healthcare, told The Loadstar the demand for cold-chain transportation and handling was “growing rapidly”.
“If we look to the future, more than half of the drugs in development are biologics, which require development in cold chain and temperature monitoring services… the ...
Volcanic disruption at Anchorage could hit transpacific airfreight operations
Shippers snap up airfreight capacity to US ahead of tariff deadline
New price hikes may slow ocean spot rate slide – but for how long?
Tighter EU import requirements proving 'a challenge' for forwarders
Forwarders stay cool as US 'liberation day' tariffs threaten 'global trade war'
Supply chain delays expected after earthquake hits Myanmar
Looming Trump tariffs will create 'a bureaucratic monster' for Customs
Comment on this article
Karen Betancourt
August 06, 2024 at 2:32 pmFascinating place to key an eye on. My concern is whether insurance limits will keep up, as the average biologic is even more expensive per manufacturer WAC than name brands.